These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 35396697

  • 1. Salubrious effects of ulinastatin and quercetin alone or in combination in endothelial dysfunction and vascular dementia.
    Sharma P, Gaur N, Jayant S, Sharma BM, Singh B, Kharkwal H, Sharma B.
    Pharmacol Rep; 2022 Jun; 74(3):481-492. PubMed ID: 35396697
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antagonism of Endothelin (ETA and ETB) Receptors During Renovascular Hypertension-Induced Vascular Dementia Improves Cognition.
    Singh P, Gupta S, Sharma B.
    Curr Neurovasc Res; 2016 Jun; 13(3):219-29. PubMed ID: 27189349
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Selective Serotonin-norepinephrine Re-uptake Inhibition Limits Renovas-cular-hypertension Induced Cognitive Impairment, Endothelial Dysfunction, and Oxidative Stress Injury.
    Singh P, Sharma B.
    Curr Neurovasc Res; 2016 Jun; 13(2):135-46. PubMed ID: 26915517
    [Abstract] [Full Text] [Related]

  • 8. Montelukast Ameliorates 2K1C-Hypertension Induced Endothelial Dysfunction and Associated Vascular Dementia.
    Gupta S, Singh P, Sharma B.
    Curr Hypertens Rev; 2024 Jun; 20(1):23-35. PubMed ID: 38192137
    [Abstract] [Full Text] [Related]

  • 9. Salutary effect of NFκB inhibitor and folacin in hyperhomocysteinemia-hyperlipidemia induced vascular dementia.
    Sharma B, Singh N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug 07; 38(2):207-15. PubMed ID: 22510463
    [Abstract] [Full Text] [Related]

  • 10. Thromboxane A2 synthase inhibition ameliorates endothelial dysfunction, memory deficits, oxidative stress and neuroinflammation in rat model of streptozotocin diabetes induced dementia.
    Bhatia P, Singh N.
    Physiol Behav; 2021 Nov 01; 241():113592. PubMed ID: 34534530
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacological inhibition of inducible nitric oxide synthase (iNOS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, convalesce behavior and biochemistry of hypertension induced vascular dementia in rats.
    Sharma B, Singh N.
    Pharmacol Biochem Behav; 2013 Feb 01; 103(4):821-30. PubMed ID: 23201648
    [Abstract] [Full Text] [Related]

  • 13. Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.
    Sharma B, Singh N.
    Psychopharmacology (Berl); 2012 Oct 01; 223(3):307-17. PubMed ID: 22526544
    [Abstract] [Full Text] [Related]

  • 14. Ozagrel a thromboxane A2 synthase inhibitor extenuates endothelial dysfunction, oxidative stress and neuroinflammation in rat model of bilateral common carotid artery occlusion induced vascular dementia.
    Bhatia P, Kaur G, Singh N.
    Vascul Pharmacol; 2021 Apr 01; 137():106827. PubMed ID: 33346090
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Arsenic toxicity induced endothelial dysfunction and dementia: pharmacological interdiction by histone deacetylase and inducible nitric oxide synthase inhibitors.
    Sharma B, Sharma PM.
    Toxicol Appl Pharmacol; 2013 Nov 15; 273(1):180-8. PubMed ID: 23921152
    [Abstract] [Full Text] [Related]

  • 17. Tadalafil ameliorates memory deficits, oxidative stress, endothelial dysfunction and neuropathological changes in rat model of hyperhomocysteinemia induced vascular dementia.
    Bhatia P, Singh N.
    Int J Neurosci; 2022 Apr 15; 132(4):384-396. PubMed ID: 32859137
    [Abstract] [Full Text] [Related]

  • 18. Neuroprotective effect of selective DPP-4 inhibitor in experimental vascular dementia.
    Jain S, Sharma B.
    Physiol Behav; 2015 Dec 01; 152(Pt A):182-93. PubMed ID: 26382939
    [Abstract] [Full Text] [Related]

  • 19. Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats.
    Sharma B, Singh N.
    Psychopharmacology (Berl); 2011 Jun 01; 215(4):677-87. PubMed ID: 21225418
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological investigations on potential of peroxisome proliferator-activated receptor-gamma agonists in hyperhomocysteinemia-induced vascular dementia in rats.
    Sain H, Sharma B, Jaggi AS, Singh N.
    Neuroscience; 2011 Sep 29; 192():322-33. PubMed ID: 21777659
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.